Logo image of MHUA

MEIHUA INTERNATIONAL MEDICAL (MHUA) Stock Fundamental Analysis

USA - NASDAQ:MHUA - KYG5966G1082 - Common Stock

0.4067 USD
+0.02 (+4.26%)
Last: 10/13/2025, 1:45:34 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to MHUA. MHUA was compared to 191 industry peers in the Health Care Equipment & Supplies industry. MHUA is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. MHUA is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year MHUA was profitable.
MHUA had a positive operating cash flow in the past year.
Each year in the past 5 years MHUA has been profitable.
In multiple years MHUA reported negative operating cash flow during the last 5 years.
MHUA Yearly Net Income VS EBIT VS OCF VS FCFMHUA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

1.2 Ratios

MHUA's Return On Assets of 7.34% is amongst the best of the industry. MHUA outperforms 90.58% of its industry peers.
MHUA has a better Return On Equity (8.48%) than 83.25% of its industry peers.
MHUA has a better Return On Invested Capital (7.79%) than 85.34% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for MHUA is below the industry average of 8.89%.
The last Return On Invested Capital (7.79%) for MHUA is above the 3 year average (6.66%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 7.34%
ROE 8.48%
ROIC 7.79%
ROA(3y)5.46%
ROA(5y)9.91%
ROE(3y)6.42%
ROE(5y)12.22%
ROIC(3y)6.66%
ROIC(5y)11.82%
MHUA Yearly ROA, ROE, ROICMHUA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

MHUA's Profit Margin of 10.37% is amongst the best of the industry. MHUA outperforms 83.25% of its industry peers.
In the last couple of years the Profit Margin of MHUA has declined.
With an excellent Operating Margin value of 13.01%, MHUA belongs to the best of the industry, outperforming 80.63% of the companies in the same industry.
MHUA's Operating Margin has declined in the last couple of years.
MHUA has a worse Gross Margin (34.04%) than 73.30% of its industry peers.
MHUA's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 13.01%
PM (TTM) 10.37%
GM 34.04%
OM growth 3Y-16.41%
OM growth 5Y-9.53%
PM growth 3Y-17.73%
PM growth 5Y-10.37%
GM growth 3Y-3.53%
GM growth 5Y-3.21%
MHUA Yearly Profit, Operating, Gross MarginsMHUA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), MHUA is creating some value.
The number of shares outstanding for MHUA has been increased compared to 1 year ago.
Compared to 5 years ago, MHUA has more shares outstanding
Compared to 1 year ago, MHUA has about the same debt to assets ratio.
MHUA Yearly Shares OutstandingMHUA Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
MHUA Yearly Total Debt VS Total AssetsMHUA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

An Altman-Z score of 2.98 indicates that MHUA is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of MHUA (2.98) is better than 68.59% of its industry peers.
The Debt to FCF ratio of MHUA is 3.19, which is a good value as it means it would take MHUA, 3.19 years of fcf income to pay off all of its debts.
MHUA has a Debt to FCF ratio of 3.19. This is amongst the best in the industry. MHUA outperforms 86.91% of its industry peers.
A Debt/Equity ratio of 0.07 indicates that MHUA is not too dependend on debt financing.
MHUA has a Debt to Equity ratio of 0.07. This is in the better half of the industry: MHUA outperforms 67.02% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 3.19
Altman-Z 2.98
ROIC/WACC1.38
WACC5.64%
MHUA Yearly LT Debt VS Equity VS FCFMHUA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

MHUA has a Current Ratio of 5.71. This indicates that MHUA is financially healthy and has no problem in meeting its short term obligations.
MHUA's Current ratio of 5.71 is amongst the best of the industry. MHUA outperforms 82.72% of its industry peers.
A Quick Ratio of 5.66 indicates that MHUA has no problem at all paying its short term obligations.
MHUA's Quick ratio of 5.66 is amongst the best of the industry. MHUA outperforms 84.82% of its industry peers.
Industry RankSector Rank
Current Ratio 5.71
Quick Ratio 5.66
MHUA Yearly Current Assets VS Current LiabilitesMHUA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 50M 100M

1

3. Growth

3.1 Past

MHUA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -22.59%.
Measured over the past years, MHUA shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -13.75% on average per year.
Looking at the last year, MHUA shows a decrease in Revenue. The Revenue has decreased by -5.30% in the last year.
The Revenue has been growing slightly by 4.01% on average over the past years.
EPS 1Y (TTM)-22.59%
EPS 3Y-27.74%
EPS 5Y-13.75%
EPS Q2Q%-35.81%
Revenue 1Y (TTM)-5.3%
Revenue growth 3Y-2.33%
Revenue growth 5Y4.01%
Sales Q2Q%-16.24%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MHUA Yearly Revenue VS EstimatesMHUA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 0.83, which indicates a rather cheap valuation of MHUA.
99.48% of the companies in the same industry are more expensive than MHUA, based on the Price/Earnings ratio.
MHUA's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.02.
Industry RankSector Rank
PE 0.83
Fwd PE N/A
MHUA Price Earnings VS Forward Price EarningsMHUA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

MHUA's Price/Free Cash Flow ratio is rather cheap when compared to the industry. MHUA is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 3.62
EV/EBITDA -0.17
MHUA Per share dataMHUA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

MHUA has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for MHUA!.
Industry RankSector Rank
Dividend Yield N/A

MEIHUA INTERNATIONAL MEDICAL

NASDAQ:MHUA (10/13/2025, 1:45:34 PM)

0.4067

+0.02 (+4.26%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-29 2022-11-29/bmo
Earnings (Next)N/A N/A
Inst Owners0.52%
Inst Owner Change0%
Ins Owners49.95%
Ins Owner ChangeN/A
Market Cap12.97M
AnalystsN/A
Price TargetN/A
Short Float %0.39%
Short Ratio0.42
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 0.83
Fwd PE N/A
P/S 0.1
P/FCF 3.62
P/OCF 3.49
P/B 0.08
P/tB 0.08
EV/EBITDA -0.17
EPS(TTM)0.49
EY120.48%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.11
FCFY27.64%
OCF(TTM)0.12
OCFY28.66%
SpS4.23
BVpS5.17
TBVpS5.16
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 7.34%
ROE 8.48%
ROCE 10.64%
ROIC 7.79%
ROICexc 8.54%
ROICexgc 8.57%
OM 13.01%
PM (TTM) 10.37%
GM 34.04%
FCFM 2.66%
ROA(3y)5.46%
ROA(5y)9.91%
ROE(3y)6.42%
ROE(5y)12.22%
ROIC(3y)6.66%
ROIC(5y)11.82%
ROICexc(3y)7.64%
ROICexc(5y)13.07%
ROICexgc(3y)7.74%
ROICexgc(5y)13.18%
ROCE(3y)8.91%
ROCE(5y)15.78%
ROICexcg growth 3Y-27.75%
ROICexcg growth 5Y-25.86%
ROICexc growth 3Y-27.69%
ROICexc growth 5Y-25.71%
OM growth 3Y-16.41%
OM growth 5Y-9.53%
PM growth 3Y-17.73%
PM growth 5Y-10.37%
GM growth 3Y-3.53%
GM growth 5Y-3.21%
F-Score5
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 3.19
Debt/EBITDA 0.63
Cap/Depr 24.05%
Cap/Sales 0.1%
Interest Coverage 69.48
Cash Conversion 20.54%
Profit Quality 25.63%
Current Ratio 5.71
Quick Ratio 5.66
Altman-Z 2.98
F-Score5
WACC5.64%
ROIC/WACC1.38
Cap/Depr(3y)500.62%
Cap/Depr(5y)471.13%
Cap/Sales(3y)2.53%
Cap/Sales(5y)2.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-22.59%
EPS 3Y-27.74%
EPS 5Y-13.75%
EPS Q2Q%-35.81%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.3%
Revenue growth 3Y-2.33%
Revenue growth 5Y4.01%
Sales Q2Q%-16.24%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-14.66%
EBIT growth 3Y-18.36%
EBIT growth 5Y-5.9%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y701.6%
FCF growth 3YN/A
FCF growth 5Y109.43%
OCF growth 1Y543.15%
OCF growth 3YN/A
OCF growth 5Y9.47%